Meetings: Clinical Laboratory Improvement Advisory Committee,

FR, March 20, 2000 › Notices › Centers for Disease Control and Prevention

Linked as:

Text

Federal Register: March 20, 2000 (Volume 65, Number 54)NoticesPage 14982-14983From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr20mr00-92

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

Clinical Laboratory Improvement Advisory Committee (CLIAC): Meeting

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following committee meetings.

Name: Clinical Laboratory Improvement Advisory Committee (CLIAC).

Times And Dates: 8:30-5 p.m., April 5, 2000; 8:30 a.m.-3:30 p.m., April 6, 2000.

Place: CDC, Koger Center, Williams Building, Conference Rooms 1802 and 1805, 2877 Brandywine Road, Atlanta, Georgia 30341.

Status: Open to the public, limited only by the space available. The meeting rooms accommodate approximately 85 people.

Purpose: This committee is charged with providing scientific and technical advice and guidance to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the need for, and the nature of, revisions to the standards under which clinical laboratories are regulated; the impact of proposed revisions to the standards; and the modification of the standards to accommodate technological advances.

Matters To Be Discussed: The agenda will include discussion on specimens and test systems not currently regulated under Clinical Laboratory Improvement Amendments (CLIA), current and future research related to CLIA, and introduction to proficiency testing issues.

The Committee solicits oral and written testimony on all three areas cited in the matters to be discussed above. Requests to make an oral presentation should be submitted in writing to the contact person listed below by close of business, March 29, 2000. All requests to make oral comments should contain the name, address, telephone number, and organizational affiliation of the presenter. Written comments should not exceed five single-spaced typed pages in length and should be received by the contact person listed below by close of business, March 29, 2000.

Agenda items are subject to change as priorities dictate.

Contact Person for Additional Information: Devery Howerton, Chief, Laboratory Practice Standards Branch, Division of Laboratory Systems, Public Health Practice Program Office, CDC, 4770 Buford Highway, NE, Mailstop F-11, Atlanta, Georgia 30341-3724, telephone 770/488-8044, FAX 770/488-8279.

The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and ATSDR.

[Page 14983]

Dated: March 14, 2000. Carolyn J. Russell, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).

FR Doc. 00-6800Filed3-17-00; 8:45 amBILLING CODE 4163-18-P